Subscribe To
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
Achieved total revenues of $38.1 million in the third quarter of 2023. Net product revenues for ZORYVE® (roflumilast) cream 0.3% were $8.1 million, a 70% increase compared to the second quarter of 2023, driven by sequential improvement in gross-to-net (GTN) down to the low 70 percent range, as well as continued demand growth Received U.S. […] The post Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update appeared first on ForexTV...
Read More
Posted: Nov 3 2023, 11:30
Author Name: forextv
Views: 112112